Immuno-oncology: understanding the function and dysfunction of the immune system in cancer.

By O. Finn. Annals of Oncology, 2012

609 citations recorded by the source corpus.

Subfields: Immunology, Oncology

View Paper: https://www.semanticscholar.org/paper/64823e358962141141fd48c8b9e6e95908774b7b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. Guido Kroemer
2. L. Galluzzi
3. L. Zitvogel
4. M. Smyth
5. Oliver Kepp
6. V. Schirrmacher
7. M. Teng
8. A. Buqué

In Oncology

1. Guido Kroemer
2. L. Galluzzi
3. L. Zitvogel
4. M. Smyth
5. Rebecca S. Y. Wong

Citations in the corpus

• Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance. (2013, background): “Such regimens can deplete both effector and suppressor cells and can impose the creation of new immune repertoires (Finn, 2012), thus ‘‘resetting’’ the immune system.”
• Development of Exosome-encapsulated Paclitaxel to Overcome MDR in Cancer cells (2015, neutral): “Furthermore, it is known that exosome-mediated cell-to-cell communication is key in the battle between cancer and the immune system (46).”